An Unusual Case of Erdheim Chester Disease (ECD) with Knee Pain: A Case Report

Background: Erdheim Chester disease (ECD) is a rare, non-Langerhans cell histiocytosis of unknown etiology that occurs in multiple organs. The clinical characteristics of ECD are unknown, making it difficult to diagnose. Case presentation: A 61-year-old woman presented with left knee pain and contracture. She had recent medical problems such as recurrent urinary tract infection, pericardial effusion, and pleural effusion. Simple radiography and magnetic resonance imaging of the knee revealed an osteosclerotic lesion. Under suspicion of malignancy, other radiologic modalities were performed, but there were no significant results showing malignancy. A bone biopsy of the knee lesion led to a final diagnosis of ECD. The patient was treated with systemic steroids and was ultimately tried on PEG-interferon. Conclusion: This report describes an unusual presentation of ECD involving the skeletal system and multiple extraskeletal organs. Owing to its non-specific nature, ECD was notably difficult to diagnose. Therefore, if a patient has knee pain and other multiorgan presentations without malignancy, clinicians should suspect ECD.

[1]  F. Said,et al.  Erdheim‐Chester disease: A multisystem disease case illustration with rare manifestations and treatment challenges , 2023, Clinical case reports.

[2]  E. Roh,et al.  A Unique Case of Erdheim-Chester Disease with Axial Skeleton, Lymph Node, and Bone Marrow Involvement , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[3]  Y. Shoenfeld,et al.  Erdheim-Chester Disease: a comprehensive review of the literature , 2013, Orphanet Journal of Rare Diseases.

[4]  Y. Choi,et al.  Erdheim Chester Disease (ECD): A Case Report , 2013 .

[5]  P. Cluzel,et al.  Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. , 2013, Blood.

[6]  C. Campochiaro,et al.  The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases , 2013, Annals of the rheumatic diseases.

[7]  J. Piette,et al.  Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis. , 2008, Blood.

[8]  J. Piette,et al.  Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature , 2006, Journal of Neurology.

[9]  P. Grenier,et al.  Cardiovascular Involvement, an Overlooked Feature of Erdheim-Chester Disease: Report of 6 New Cases and a Literature Review , 2004, Medicine.

[10]  V. Leblond,et al.  Treatment of refractory Erdheim-Chester disease with double autologous hematopoietic stem-cell transplantation. , 2001, Annals of internal medicine.

[11]  K. Ryu,et al.  Erdheim-Chester disease: a case report. , 1999, Journal of Korean medical science.

[12]  B. Brewer,et al.  Erdheim-Chester disease: low low-density lipoprotein levels due to rapid catabolism. , 1997, Metabolism: clinical and experimental.

[13]  H. Petit,et al.  Erdheim‐Chester Disease Clinical and Radiologic Characteristics of 59 Cases , 1996, Medicine.

[14]  H. Genant,et al.  Erdheim-Chester disease. , 1982, Radiology.

[15]  H. Atkins,et al.  Lipid (Cholesterol) Granulomatosis (Chester-Erdheim Disease) and Congenital Megacalices , 1978, Clinical nuclear medicine.

[16]  Dr. William Chester Über Lipoidgranulomatose , 2005, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.